Biotech

All Articles

Editas capitalize Tip Cas9 licensing legal rights for $57M

.Versus the background of a Cas9 patent fight that refuses to pass away, Editas Medicine is moneying...

Ultragenyx fine-tunes gene therapy dosing to dial up effectiveness

.A minority of clients taking Ultragenyx Pharmaceutical's Wilson condition genetics therapy UX701 ha...

Biopharma unemployment cost supports in Q3: Ferocious Biotech analysis

.As summer warmth turns to cool down winds, really hopes that this year will deliver common field re...

J &amp J falls stage 2 dengue prospect in most recent shift from vaccinations

.Johnson &amp Johnson's deprioritization of its own infectious health condition pipeline has actuall...

Relay sheds 10% of team after earlier unemployments in July

.Accuracy medicine biotech Relay Therapeutics is losing about 10% of its own workforce in efforts to...

Pentixapharm scores $22M IPO to deposit radiopharma trials

.Pentixapharm has actually introduced virtually 20 thousand europeans ($ 22 thousand) coming from an...

Lundbeck faucets Charles Stream for AI-enabled neuro medication breakthrough

.Lundbeck has used Charles River Laboratories' artificial intelligence abilities to help the inventi...

Big pharma, biotech 'won't essentially be actually symbiotic' in artificial intelligence: S&ampP

.Significant Pharma is spending heavily in artificial intelligence to slash development timelines an...

I &amp I biotech Triveni increases $115M for preclinical antitoxins

.Triveni Bio has trapped $115 thousand in series B funds to advance preclinical antitoxin courses cr...

IGM turns coming from cancer cells to autoimmune, shocking C-suite

.IGM Biosciences finished in 2013 laying off personnel and also enhancing its own cancer cells pipe....